MedTrace Logo

Internet-based Psychodynamic Therapy Compared to Behavioral Activation - a Randomized Controlled Trial

NCT05109741 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2023-10-03

No results posted yet for this study

Summary

There are several treatment options for depression, including Internet-delivered psychotherapy. While a majority of this research is based on cognitive behavior therapy (ICBT), there are also several recent studies investigating Internet-delivered psychodynamic therapy (IPDT). Importantly though, these treatments have never been directly compared in a randomized controlled trial.

In this project, we aim to include 350 patients with depression randomized to ten weeks of IPDT (N=150), ICBT in the form of behavioral activation (N=150) or waiting list (N=50). After the end of the treatment period, patients on the waiting list will also be offered treatment. A secure web platform (KI eHealth Core Facility) will be used to provide treatment via the Internet.

Symptoms of depression will be measured weekly and the effect will be evaluated by comparing the change in the treatment groups with each other and with the change in the waiting list group. Treatment effects and predictors of treatment response will be examined.

In summary, this project is an important step in the continued evaluation of internet-based psychological treatments for depression.

Conditions

Interventions

BEHAVIORAL

Internet-based Psychodynamic Therapy

Internet-based Psychodynamic Therapy based on the SUBGAP model developed by Farrell Silverberg

BEHAVIORAL

Internet-based Behavioral Activation

Internet-based Behavioral Activation based on the BATD-R model developed by Carl Lejuez and others.

Sponsors & Collaborators

Principal Investigators

  • Robert Johansson, PhD · Stockholm University and Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-04
Primary Completion
2021-12-15
Completion
2023-05-15

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05109741 on ClinicalTrials.gov